BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Spineology Inc. Secures $7.5 Million in Financing; Company Poised to Expand Commercialization and Development in $4 Billion Spine Market


7/15/2008 6:29:46 AM

ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology Inc., manufacturer of the OptiMesh Deployable Grafting System and pioneer in developing minimally invasive spinal surgery devices, has closed on $7.5 million financing. The proceeds from this financing are expected to fund additional commercialization, product development and clinical research efforts for the company, which serves the $4 billion spinal market.

“We’re at a pivotal stage in our growth process,” said John Booth, CEO for Spineology. “The company has made significant strides in many areas over the last few years with very limited capital resources. With this new capital, we are well positioned to expand on all fronts of the business.”

This round of financing was a private placement, led by Minneapolis-based Oakridge Financial and includes multiple investors. The finance announcement follows the recent addition of eight direct sales representatives and the ongoing expansion of Spineology’s distributor network.

“Spineology is an exciting story,” said Tom Niemiec, of Oakridge Financial. “The company has moved to the forefront in spinal device innovation. As it continues to grow, Spineology will be a company to watch.”

About Spineology

Founded in 1997, Spineology has become a MIS pioneer in the spinal implant industry. The company’s platform technology, The OptiMesh System, is designed to enable spine surgery to be done in a dramatically less invasive manner. The OptiMesh Deployable Grafting System works by allowing implants to be inserted empty and then deployed to their full size, once in position. The OptiMesh implant is currently FDA-cleared in the United States and CE-marked in Europe. Spineology is headquartered in St. Paul, Minn. For more information, please visit www.spineology.com

Contact:

John Booth, 651-256-8511 Spineology, Inc. jbooth@spineology.com or Anne Schopen, 651-286-6742 Risdall McKinney Public Relations aschopen@risdall.com

Source: Spineology Inc.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES